Passa al contenuto
Merck

Vai a

P0424

Prostaglandin F tris salt

≥99%, synthetic, powder

Sinonimo/i:

(5Z,9α,11α,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt, PGF−Tris

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
A voi/SKUDisponibilitàPrezzo

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C20H34O5 · C4H11NO3
Numero CAS:
Peso molecolare:
475.62
NACRES:
NA.77
PubChem Substance ID:
eCl@ss:
42020658
UNSPSC Code:
12352401
EC Number:
254-002-3
MDL number:
Beilstein/REAXYS Number:
4087514
Prezzi e disponibilità al momento non sono disponibili
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


biological source

synthetic

Quality Segment

assay

≥99%

form

powder

color

white

solubility

H2O: 1 mg/mL, ethanol: 50 mg/mL

functional group

carboxylic acid, hydroxyl

shipped in

ambient

storage temp.

−20°C

SMILES string

NC(CO)(CO)CO.[H][C@]1(C\C=C/CCCC(O)=O)[C@@H](O)C[C@@H](O)[C@]1([H])\C=C\[C@@H](O)CCCCC

InChI

1S/C20H34O5.C4H11NO3/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25;5-4(1-6,2-7)3-8/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25);6-8H,1-3,5H2/b7-4-,13-12+;/t15-,16+,17+,18-,19+;/m0./s1

InChI key

IYGXEHDCSOYNKY-RZHHZEQLSA-N

Gene Information

human ... PTGFR(5737)

General description

Aqueous solutions are stable for 30 days at 2-8°C and for several months frozen at −0°C in single use aliquots. Avoid repeated freeze/thaw cycles.

Biochem/physiol Actions

Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds.
Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. A positive feedback loop between endometrial PG F and luteal oxytocin is responsible for completion of luteolysis.
Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. Also stimulates contraction of smooth muscle, such as in bronchi, with possible involvement in asthma. This effect is at least partially mediated through tachykinin release.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
P5069P6188P5640
biological source

synthetic

biological source

synthetic

biological source

synthetic

biological source

synthetic

functional group

carboxylic acid, hydroxyl

functional group

-

functional group

carboxylic acid, hydroxyl

functional group

carboxylic acid, hydroxyl

assay

≥99%

assay

≥99%

assay

≥96% (HPLC)

assay

≥93% (HPLC)

shipped in

ambient

shipped in

ambient

shipped in

ambient

shipped in

ambient

solubility

H2O: 1 mg/mL, ethanol: 50 mg/mL

solubility

ethanol: 50 mg/mL, clear, colorless

solubility

H2O: 1 mg/mL (Hydrolyzes to 6-ketoprostaglandin F in aqueous solution.), ethanol: 50 mg/mL

solubility

-

form

powder

form

powder

form

powder

form

powder


Still not finding the right product?

Explore all of our products under Prostaglandin F tris salt


pictograms

Health hazardExclamation mark

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Repr. 1B

Classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

ppe

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti



Questions

Reviews

No rating value

Active Filters